Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (23298)	7/17/1998 1:02:00 PM
From: Mudcat	Read Replies (1) \| Respond to of 32384

<Did AGN do an SEC filing indicating that they owned over 5% of LGND or report any sales prior to their press release this week?> I have no idea if AGN made an SEC filing. However, if I remember what I read in the press release, I think AGN said that their gain on the sale of Lgnd stock accounted for .06 cents of their quarterly profit. I don't know how many shares outstanding AGN has, but if you take that number and times by .06 you will see how much profit AGN made on Lgnd's stock.

To: Henry Niman who wrote (23298)	7/17/1998 1:08:00 PM
From: Mudcat	Read Replies (1) \| Respond to of 32384

I found the press release here are the exact words: "Allergan realized a pre-tax gain of $5.5 million, or $0.06 per share after tax, from the sale of the Ligand stock. Allergan intends to continue reducing its holdings of Ligand common stock on a selective basis over the next several quarters." Looks like a gain of 5.5M so they must have sold quite a few shares. They also state that they will CONTINUE reducing its holdings of Ligand over the next several quarters. So Henry is this proof enough for you that AGN has been and will be continuing to sell Lgnd stock.